HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Modification of behavioral effects of drugs in mice by neuroactive steroids.

AbstractRATIONALE:
Neuroactive steroids represent a novel class of potential therapeutic agents (epilepsy, anxiety, migraine, drug dependence) thought to act through positive allosteric modulation of the GABA(A) receptor. A synthetically derived neuroactive steroid, ganaxolone (3alphahydroxy-3beta-methyl-5alpha-pregnan-20-one), is in phase-II clinical trials for epilepsy. Unlike traditional anticonvulsants such as diazepam and phenobarbital, ganaxolone shows equipotent suppression of both the seizure activity and the behavioral effects of pentylenetetrazol (PTZ) administration.
OBJECTIVES:
The present study explored possible reversal by ganaxolone and related neuroactive steroids of some behavioral effects of additional pharmacological challenges.
METHODS:
Direct behavioral observation and photocell-counted locomotor activity of male, Swiss-Webster mice were made with various compounds alone and in conjunction with ganaxolone.
RESULTS:
Ganaxolone both prevented and reversed PTZ-induced locomotor depression in mice. Further, ganaxolone reversed the locomotor depression induced by other convulsant/anxiogenic stimuli: bicuculline, picrotoxin and, to a lesser extent, yohimbine. Ganaxolone failed to reverse the locomotor stimulation induced by cocaine, methamphetamine, dizocilpine, and phencyclidine. In addition to ganaxolone, the endogenous neuroactive steroids allopregnanolone and pregnanolone and the synthetic neuroactive steroid Co 2-1068 also reversed observed behaviors and locomotor depression induced by PTZ.
CONCLUSIONS:
The present findings support the unique pharmacological effects of neuroactive steroids as a novel class of positive allosteric modulators of GABA.
AuthorsJ T Ungard, M Beekman, M Gasior, R B Carter, D Dijkstra, J M Witkin
JournalPsychopharmacology (Psychopharmacology (Berl)) Vol. 148 Issue 4 Pg. 336-43 (Mar 2000) ISSN: 0033-3158 [Print] Germany
PMID10928304 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Anticonvulsants
  • Central Nervous System Stimulants
  • Convulsants
  • Dopamine Uptake Inhibitors
  • Psychotropic Drugs
  • Steroids
  • gamma-Aminobutyric Acid
  • Pregnenolone
  • ganaxolone
  • Pregnanolone
  • Cocaine
  • Pentylenetetrazole
Topics
  • Animals
  • Anticonvulsants (pharmacology)
  • Behavior, Animal (drug effects)
  • Central Nervous System Stimulants (antagonists & inhibitors, pharmacology)
  • Cocaine (antagonists & inhibitors, pharmacology)
  • Convulsants (pharmacology)
  • Dopamine Uptake Inhibitors (antagonists & inhibitors, pharmacology)
  • Dose-Response Relationship, Drug
  • Male
  • Mice
  • Motor Activity (drug effects)
  • Pentylenetetrazole (antagonists & inhibitors, pharmacology)
  • Pregnanolone (analogs & derivatives, pharmacology)
  • Pregnenolone (pharmacology)
  • Psychotropic Drugs (antagonists & inhibitors, pharmacology)
  • Steroids (pharmacology)
  • Synaptic Transmission (drug effects)
  • gamma-Aminobutyric Acid (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: